发明名称 |
Essential fatty acids in the prevention of cardiovascular events. |
摘要 |
Use of essential fatty acids containing at least 25% of a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA) in the preparation of a medicament for preventing mortality in a patient who had suffered myocardial infarction is new. Independent claims are included for: (i) use of essential fatty acids containing at least 25% of EPA or DHA in the preparation of a medicament for preventing mortality in a patient who had suffered myocardial infarction; (ii) a method for preventing mortality in a patient who has survived myocardial infarction comprising administration of a mixture of essential fatty acids containing at least 25% EPA+DHA; (iii) a method for preventing mortality in a patient who has survived myocardial infarction comprising administration of a mixture of essential fatty acids containing at least 25% of EPA or DHA. |
申请公布号 |
ZA200106029(B) |
申请公布日期 |
2002.09.25 |
申请号 |
ZA20010006029 |
申请日期 |
2001.07.23 |
申请人 |
PHARMACIA & UPJOHN S.P.A. |
发明人 |
FRANCO PAMPARANA |
分类号 |
A61P7/02;A61K;A61K31/23;A61K31/231;A61K31/232;A61P;A61P9/10;C07C |
主分类号 |
A61P7/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|